Stock listing

IVA Stock Price, News, Filings & Events — Inventiva Sa

Selected listing: IVA · NASDAQ · USD · US

This page tracks Inventiva Sa's IVA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IVA:NASDAQ. IVA:NASDAQ is the stock-level entry point for investors researching Inventiva Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Inventiva SA is a public company listed on the French market under the ticker IVA. With a market capitalization of approximately €1.04 billion, the company focuses on developing innovative treatments for various diseases. Its commitment to research and development positions it as a key player in the healthcare sector.

IVA:NASDAQUSDUSUpdated September 18, 2026
Inventiva Sa logo
Ticker
IVA:NASDAQ
Asset type
Stock
Market cap
$898.8M
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

Inventiva Sa IVA:NASDAQ stock context

This page tracks Inventiva Sa's IVA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IVA:NASDAQ. IVA:NASDAQ is the stock-level entry point for investors researching Inventiva Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Inventiva SA is a public company listed on the French market under the ticker IVA. With a market capitalization of approximately €1.04 billion, the company focuses on developing innovative treatments for various diseases. Its commitment to research and development positions it as a key player in the healthcare sector.

Latest news from Inventiva Sa

All Inventiva Sa news →

Inventiva Sa earnings calls

Research Inventiva Sa

Alternate listings